Tag: Cerus

By Posted on Posted in Fundamental Valuation Report

Fundamental Valuation Report Cerus(CERS:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$5.84 (USD) 04/20/2021 Weighted Valuation$5.90 (USD) Overall RatingFairly valued to slightly Undervalued by 1.0% Valuation Models Adjusted Book …

Cerus (CERS:NAS) Fundamental Valuation Report Read more »

Read More

By Posted on Posted in Uncategorised

Fundamental Valuation Report Apellis Pharmaceuticals(APLS:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$14.24 (USD) 27/02/2019 Weighted Valuation$37.26 (USD) Overall RatingUndervalued by 161.7% Valuation Models Analyst Consensus: $53.00 (USD) (in …

Apellis Pharmaceuticals (APLS:NAS) Fundamental Valuation Report Read more »

Read More